GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Future 3-5Y Total Revenue Growth Rate

SNY (Sanofi) Future 3-5Y Total Revenue Growth Rate : 4.82 (As of Oct. 31, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sanofi Future 3-5Y Total Revenue Growth Rate?

Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Sanofi's Future 3-5Y Total Revenue Growth Rate is 4.82.


Competitive Comparison of Sanofi's Future 3-5Y Total Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Sanofi's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi's Future 3-5Y Total Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Sanofi's Future 3-5Y Total Revenue Growth Rate falls into.



Sanofi  (NAS:SNY) Future 3-5Y Total Revenue Growth Rate Explanation

Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Sanofi Future 3-5Y Total Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Sanofi's Future 3-5Y Total Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Future 3-5Y Total Revenue Growth Rate
Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

From GuruFocus

Q3 2022 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024

Sanofi SA ATS Investor Call Transcript

By GuruFocus Research 02-09-2024

Q2 2024 Sanofi SA Earnings Call Transcript

By GuruFocus Research 07-26-2024

Sanofi SA's Dividend Analysis

By GuruFocus Research 05-08-2024

Q4 2022 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q4 2023 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024